Boston Scientific Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | $3.82B | $7.01B | $188.0M |
| FY2018 | $4.80B | $8.73B | $146.0M |
| FY2019 | $8.59B | $13.88B | $217.0M |
| FY2020 | $9.13B | $15.33B | $1.73B |
| FY2021 | $8.80B | $16.62B | $1.93B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | $3.82B | $7.01B | $188.0M |
| FY2018 | $4.80B | $8.73B | $146.0M |
| FY2019 | $8.59B | $13.88B | $217.0M |
| FY2020 | $9.13B | $15.33B | $1.73B |
| FY2021 | $8.80B | $16.62B | $1.93B |